genXone S.A. (WSE:GX1)

Market Cap	14.51M
Revenue (ttm)	2.03M
Net Income (ttm)	-3.40M
Shares Out	3.30M
EPS (ttm)	-1.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3
Average Volume	2,816
Open	4.390
Previous Close	4.390
Day's Range	4.390 - 4.390
52-Week Range	3.810 - 7.740
Beta	-0.47
RSI	48.62
Earnings Date	Feb 10, 2026

About genXone

genXone S.A. operates as a biotechnology company that offers nucleic acid sequencing services based on nanopore sequencing technology in Poland and internationally. The company operates in the field of molecular genetics and bioinformatics. It also develops solutions in the form of laboratory protocols, as well as bioinformatics tools, scripts, and algorithms enabling the use of nanopore sequencing in various areas of science and business, including genetic diagnostics, food industry, veterinary medicine, and agriculture. genXone S.A. was incor...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 2018
• Employees: 16
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: GX1

Financial Performance

In 2024, genXone's revenue was 1.79 million, a decrease of -25.33% compared to the previous year's 2.39 million. Losses were -3.93 million, 5.58% more than in 2023.